HEGDE SHARATHCHANDRA S 4
4 · Theravance Biopharma, Inc. · Filed Feb 22, 2018
Insider Transaction Report
Form 4
HEGDE SHARATHCHANDRA S
SVP, Research
Transactions
- Tax Payment
Ordinary Shares
2018-02-20$29.09/sh−4,349$126,512→ 159,611 total
4 · Theravance Biopharma, Inc. · Filed Feb 22, 2018
Ordinary Shares